Zein Pharma D-Ribose 200 g

Zein Pharma D-Ribose 200 g dietary supplement is a simply formulated product containing D-ribose in the form of a water-soluble powder. It contains no artificial additives or allergens such as gluten, lactose, or soy. It can be used by vegans and vegetarians.

Ribose is an organic chemical compound, a sugar with five carbon atoms and a slightly sweet taste. It is very well water-soluble. It naturally occurs in nucleosides and nucleotides bound to RNA and the cellular energy carrier molecule ATP. Additionally, it is found in coenzyme A, vitamin B2, and B12. Repeatedly tested, it is a substance of high safety.

Studies have found that D-ribose can play an inhibitory role in the breakdown of adenine nucleotides. This affects the subsequent formation of xanthine and uric acid compounds and thus influences the release of superoxide anion radicals. Free oxygen radicals damage genetic material, proteins, and lipids in the cell. The combination of D-ribose with reducing antioxidants can provide optimal cell protection during and after oxidative stress. [1]

Interestingly, the effect of D-ribose has also been studied in patients with fibromyalgia, a condition that causes muscle soreness and fatigue. Published results show a positive effect of this sugar on clinical symptoms, including a reduction in muscle soreness and a slight improvement in overall well-being in patients with this condition. [2]

In summary, Zein Pharma D-Ribose 200 g is a dietary supplement containing D-ribose, a component of extremely important biologically active compounds. This simple sugar plays a number of important metabolic roles in the human body. The supplement is delivered in the form of a water-soluble powder. It has a simple and pure composition.

1 Addis P, Shecterle LM, St Cyr JA. Cell protection during oxidative stress: a possible role for D-ribose and antioxidants. J Diet Suppl. 2012 Sep;9(3):178-82. doi: 10.3109/19390211.2012.708715. PMID: 22891990.

2 Teitelbaum JE, Johnson C, St Cyr J. The use of D-ribose in chronic fatigue syndrome and fibromyalgia: a pilot study. J Altern Complement Med. 2006 Nov;12(9):857-62. doi: 10.1089/acm.2006.12.857. PMID: 17109576.